Search

everythinglearnresearchcommunity

for

Search:↓

Somatostatin analogues effectively manage ectopic ACTH syndrome when surgery isn't possible.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Long-term minoxidil use can cause pseudoacromegaly, but stopping it improves symptoms.

Electrospun nanofibers are promising for medical, sensing, and energy uses, especially with 3D printing.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

The formulation with oleic acid may be better for treating male pattern baldness.

Dutasteride-loaded nanoparticles coated with Lauric Acid-Chitosan show promise for treating hair loss due to their controlled release, low toxicity, and potential to stimulate hair growth.

STS01 1% effectively promotes hair regrowth with minimal side effects.

The new delivery system improved hair growth in alopecia treatment.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

A woman got a scalp condition from using latanoprost, but it improved after stopping the drug and starting other treatments.

Trilostane helped a cat with a hormone issue but the cat later died from a kidney infection.

Trilostane helped a dog with an adrenal tumor feel better and stay healthy.

Clascoterone cream could be used for other skin conditions affected by hormones.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.